Original
Serum cystatin C versus creatinine in the assessment
of allograft function in early periods of kidney
transplantation
Ali Taghizadeh-Afshari 1, Mohammadreza Mohammadi-Fallah 1, Mansour Alizadeh 1, Saeed Abkhiz 1, Rohollah Valizadeh 2, Mohammad Hassan Khadem-Ansari 3, Hojjat Sayyadi 4, Sadegh Asgari Kashani 5, Mohsen Mohammad Rahimi 1 *
Cited by CrossRef: 3
1- Jimenez-Coll V, Llorente S, Boix F, Alfaro R, Galián J, Martinez-Banaclocha H, Botella C, Moya-Quiles M, Muro-Pérez M, Minguela A, Legaz I, Muro M. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome. IJMS. 2023;24(4):3908 [Crossref]
2- Asmamaw T, Genet S, Menon M, Tarekegn G, Chekol E, Geto Z, Lejisa T, Habtu W, Getahun T, Tolcha Y. Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
. DMSO. 2020;Volume 13:4727 [Crossref]
3- Rogulska K, Wojciechowska-Koszko I, Dołęgowska B, Kwiatkowska E, Roszkowska P, Kapczuk P, Kosik-Bogacka D, Hautz T. The Most Promising Biomarkers of Allogeneic Kidney Transplant Rejection. Journal of Immunology Research. 2022;2022:1 [Crossref]